Deciphering PARP inhibitors in pancreatic cancerAnd then add in ONCY's oncolytic virus pelareorep in combination with CPIs and PARP inhibitors, as I've posted on beforehand.
https://aacrjournals.org/clincancerres/article-abstract/29/24/5005/731668/Deciphering-the-Pathways-to-PARP-Sensitivity-in?redirectedFrom=fulltext